在炎症性肠病中,由巨细胞衍生的外体通过通过mircroRNA-22323调节TMIGD1,促进肠粘膜屏障功能障碍

Xin Chang1, Yi-Hang Song2, Tian Xia2

  • 1Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China; Department of Gastroenterology, the General Hospital of Central Theater Command, Wuhan, China.

概括

携带miR-223的巨细胞衍生外体通过破坏肠道屏障,使炎症性肠病 (IBD) 恶化. 这项研究确定miR-223是通过TMIGD1抑制IBD进展的关键参与者.